Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA

Rae Sung Chang, Min Sung Suh, Sunil Kim, Gayong Shim, Sangbin Lee, Sung Sik Han, Kyung Eun Lee, Hyesung Jeon, Han Gon Choi, Yongseok Choi, Chan Wha Kim, Yu Kyoung Oh

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Combined treatment of anticancer drugs and small interfering RNAs (siRNAs) have emerged as a new modality of anticancer therapy. Here, we describe a co-delivery system of anticancer drugs and siRNA in which anticancer drug-derived lipids form cationic nanoparticles for siRNA complexation. The anticancer drug mitoxantrone (MTO) was conjugated to palmitoleic acid, generating two types of palmitoleyl MTO (Pal-MTO) lipids: monopalmitoleyl MTO (mono-Pal-MTO) and dipalmitoleyl MTO (di-Pal-MTO). Among various lipid compositions of MTO, nanoparticles containing mono-Pal-MTO and di-Pal-MTO at a molar ratio of 1:1 (md11-Pal-MTO nanoparticles) showed the most efficient cellular delivery of siRNA, higher than that of Lipofectamine 2000. Delivery of red fluorescence protein-specific siRNA into B16F10-RFP cells using md11-Pal-MTO nanoparticles reduced the expression of RFP at both mRNA and protein levels, demonstrating silencing of the siRNA target gene. Moreover, delivery of Mcl-1-specific anticancer siRNA (siMcl-1) using md11-Pal-MTO enhanced antitumor activity in vitro, reducing tumor cell viability by 81% compared to a reduction of 68% following Lipofectamine 2000-mediated transfection of siMcl-1. Intratumoral administration of siMcl-1 using md11-Pal-MTO nanoparticles significantly inhibited tumor growth, reducing tumor size by 83% compared to untreated controls. Our results suggest the potential of md11-Pal-MTO multifunctional nanoparticles for co-delivery of anticancer siRNAs for effective combination therapy.

Original languageEnglish
Pages (from-to)9785-9795
Number of pages11
JournalBiomaterials
Volume32
Issue number36
DOIs
Publication statusPublished - 2011 Dec

Keywords

  • Anticancer chemo-gene therapy
  • Co-delivery
  • Mitoxantrone
  • Multifunctional nanoparticles
  • SiRNA

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Fingerprint Dive into the research topics of 'Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA'. Together they form a unique fingerprint.

Cite this